GSTO2 and cancer: Here, subjects with the homozygous wild-type GSTO2*N142 genotype (N/N) and with a positive family history were found to be at a high risk for developing colorectal cancer, when compared to subjects with other genotypes (i.e., D/D or N/D) and a negative family history of cancer.